CICERI, FABIO
 Distribuzione geografica
Continente #
AS - Asia 18.614
NA - Nord America 10.670
EU - Europa 8.551
SA - Sud America 5.563
AF - Africa 365
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 43.811
Nazione #
US - Stati Uniti d'America 10.130
SG - Singapore 8.249
CN - Cina 4.774
BR - Brasile 4.630
HK - Hong Kong 2.613
SE - Svezia 2.274
IT - Italia 2.243
VN - Vietnam 1.483
RU - Federazione Russa 976
DE - Germania 778
GB - Regno Unito 406
AR - Argentina 382
FI - Finlandia 318
IN - India 316
RO - Romania 276
NL - Olanda 251
CA - Canada 247
AT - Austria 245
JP - Giappone 196
MX - Messico 189
EC - Ecuador 172
BD - Bangladesh 160
ID - Indonesia 149
FR - Francia 146
PL - Polonia 146
ZA - Sudafrica 145
IE - Irlanda 134
TR - Turchia 121
ES - Italia 108
IQ - Iraq 102
PY - Paraguay 93
CO - Colombia 89
PK - Pakistan 66
CL - Cile 60
LT - Lituania 54
UA - Ucraina 51
VE - Venezuela 51
MA - Marocco 49
UZ - Uzbekistan 45
EG - Egitto 42
PE - Perù 36
UY - Uruguay 36
AU - Australia 35
SA - Arabia Saudita 35
IR - Iran 34
AE - Emirati Arabi Uniti 32
DZ - Algeria 32
IL - Israele 31
TN - Tunisia 29
KE - Kenya 23
KR - Corea 22
BE - Belgio 20
KZ - Kazakistan 19
AZ - Azerbaigian 18
CH - Svizzera 18
DO - Repubblica Dominicana 18
JO - Giordania 18
NP - Nepal 17
JM - Giamaica 14
AL - Albania 13
ET - Etiopia 13
HN - Honduras 13
LB - Libano 12
PH - Filippine 12
BY - Bielorussia 11
PA - Panama 10
TH - Thailandia 10
TT - Trinidad e Tobago 10
BH - Bahrain 9
BO - Bolivia 9
CZ - Repubblica Ceca 9
DK - Danimarca 9
KW - Kuwait 9
PT - Portogallo 9
SV - El Salvador 9
BG - Bulgaria 8
CR - Costa Rica 8
GR - Grecia 8
SY - Repubblica araba siriana 8
TW - Taiwan 8
BA - Bosnia-Erzegovina 7
BW - Botswana 7
NZ - Nuova Zelanda 7
OM - Oman 7
PS - Palestinian Territory 7
AO - Angola 6
GT - Guatemala 6
HU - Ungheria 6
MY - Malesia 6
AM - Armenia 5
CI - Costa d'Avorio 5
GE - Georgia 5
NG - Nigeria 5
NI - Nicaragua 5
NO - Norvegia 5
RS - Serbia 5
BB - Barbados 4
LV - Lettonia 4
MK - Macedonia 4
CY - Cipro 3
Totale 43.762
Città #
Singapore 3.515
Hong Kong 2.593
Dallas 1.971
Ashburn 1.340
Shanghai 1.284
Hefei 1.094
Lawrence 812
Princeton 811
Milan 650
Beijing 577
New York 556
Ho Chi Minh City 554
São Paulo 428
Moscow 354
Hanoi 306
Los Angeles 305
Nuremberg 238
Boardman 214
Rome 177
Munich 176
Helsinki 161
Rio de Janeiro 148
Tokyo 131
Dublin 124
Warsaw 122
Vienna 116
Brooklyn 113
Belo Horizonte 106
Denver 103
Washington 98
Cesano Boscone 96
Santa Clara 95
Montreal 94
Johannesburg 88
Guangzhou 86
Chennai 82
Stockholm 82
Lappeenranta 80
Brasília 78
Poplar 78
London 77
Curitiba 76
Brescia 72
Turku 71
Seattle 70
Campinas 67
Atlanta 65
Guayaquil 63
Mexico City 63
Orem 63
Ankara 62
Toronto 62
Castelseprio 61
Pune 61
Boston 60
Haiphong 60
Chicago 59
The Dalles 59
Quito 58
Amsterdam 56
Porto Alegre 56
Manchester 54
Salvador 53
Phoenix 52
Frankfurt am Main 51
Da Nang 49
Houston 46
Hangzhou 45
Biên Hòa 44
Bologna 41
Tashkent 41
Guarulhos 40
Santo André 40
Goiânia 39
Council Bluffs 37
Shenzhen 37
Tianjin 37
Buenos Aires 36
Columbus 35
Hải Dương 35
Jakarta 34
Baghdad 33
Dhaka 33
San Francisco 33
Thái Bình 33
Bergamo 32
Manaus 31
Ribeirão Preto 31
Turin 30
Chandler 29
Montevideo 29
Shijiazhuang 29
Changsha 28
Monza 28
Mumbai 28
Querétaro 28
Sorocaba 28
Falkenstein 26
Lima 26
São Gonçalo 26
Totale 22.784
Nome #
Addition of a Single Low Dose of Anti T-Lymphocyte Globulin to Post-Transplant Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplant: A Pilot Study 343
Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy 326
Use of HSV-TK transduced donor lymphocytes in the context of allogeneic bone marrow transplantation: A paradigm of current applications and limitations in gene therapy 191
Rapamycin-Based GvHD Prophylaxis Is Effective in T-Cell Replete Unmanipulated Haploidentical Peripheral Stem Cell Transplantation for Advanced Haematological Malignancies: Results in 46 Patients 191
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses 164
Loss of mismatched HLA in leukemia after stem-cell transplantation 133
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 131
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 131
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation 123
Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation 119
A longitudinal analysis of humoral, T cellular response and influencing factors in a cohort of healthcare workers: Implications for personalized SARS-CoV-2 vaccination strategies 117
Clinical impact of suicide gene therapy in allogeneic hematopoietic stem cell transplantation 113
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency 113
Flotetuzumab as Salvage Immunotherapy for Refractory Acute Myeloid Leukemia 112
Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir 111
Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress 109
Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors 108
Impact of Levofloxacin for Prophylaxis of Pre-engraftment Bloodstream Infections after Allogeneic HSCT: A single-center Matched Analysis in an Endemic Country for Carbapenem-resistant Gram-negative Bacteria 108
Gas-exchange deficit and systemic hypoperfusion in COVID-19 and non-COVID-19 young adult patients with pneumonia 108
Immune Effector Cell-Associated Hematotoxicity (ICAHT): EHA/EBMT Consensus Grading and Best Practice Recommendations 106
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors 106
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 106
Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia 105
A New Clinicobiological Scoring System for the Prediction of Infection-Related Mortality and Survival after Allogeneic Hematopoietic Stem Cell Transplantation 105
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access 105
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study 102
Validation of the “fitness criteria” for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (REL) 102
A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous Disease 100
A Nomogram-Based Model to Predict Respiratory Dysfunction at 6 Months in Non-Critical COVID-19 Survivors 100
Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies 98
A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID 97
Chest CT-derived pulmonary artery enlargement at the admission predicts overall survival in COVID-19 patients: insight from 1461 consecutive patients in Italy 96
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 94
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 94
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 93
Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy 93
A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells 92
Systemic delivery of cadherin 17–specific CAR T cells allows effective and safe targeting of colorectal cancer liver metastases 91
A multicentre, multinational, prospective, observational registry study of defibrotide in patients diagnosed with veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation: an EBMT study 91
A Novel t(5;7)(q31;q21)/CDK6::IL3 in Immature T-cell Acute Lymphoblastic Leukemia With IL3 Expression and Eosinophilia 90
Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency 90
A novel genomic inversion in Wiskott-Aldrich-associated autoinflammation 90
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 90
Hematopoietic stem-and progenitor-cell gene therapy for hurler syndrome 90
Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier 89
Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients 88
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia 87
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 86
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia 86
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: An open-label cohort study 85
Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification 85
Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party 84
A T cell epitope encoded by a subset HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation 84
Biobanking for COVID-19 research 84
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine 84
TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells 82
Bone marrow as source of hematopoietic stem cells for human gene therapy of beta thalassemia 82
A phase II multicenter trial of HSV-TK engineered donor lymphocytes after haplo-identical HSCT: Early immune reconstitution and abrogation of GvHD 82
Erratum: IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism (Molecular Therapy (2017) 25(10) (2254–2269), (S1525001617303143), (10.1016/j.ymthe.2017.06.029)) 82
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation 81
CPX-351 and allogeneic stem cell transplant for a therapy-related acute myeloid leukemia that developed after treatment of acute promyelocytic leukemia: a case report and review of the literature 81
Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapy 81
miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease 80
Prevalence, Characteristics, Risk Factors, and Outcomes of Invasively Ventilated COVID-19 Patients with Acute Kidney Injury and Renal Replacement Therapy 80
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia 79
A novel self-lipid antigen targets human T cells against CD1c(+) leukemias 79
A new tool for rapid and reliable diagnosis of HLA loss relapses after HSCT 79
COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike Receptor Binding Domain 79
Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study 79
Physical and psychological sequelae at three months after acute illness in COVID-19 survivors 79
ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub 78
Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study 78
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 78
Results from the HLA COVID-Italia study: An unexpected correlation between HLA-DP antigen load and COVID-19 severity 77
Gene therapy for immunodeficiency due to adenosine deaminase deficiency 77
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 77
Initial chest radiographs and artificial intelligence (AI) predict clinical outcomes in COVID-19 patients: analysis of 697 Italian patients 77
Peripheral blood stem and progenitor cell collection in pediatric candidates for ex vivo gene therapy: a 10-year series 77
QTc interval prolongation, inflammation, and mortality in patients with COVID-19 76
Long-term lineage commitment in haematopoietic stem cell gene therapy 75
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation 75
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer 75
A dual role for genetically modified lymphocytes in cancer immunotherapy 75
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies 75
Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation 74
A PHASE II STUDY ON INTENSIVE ALL TYPE CHEMOTHERAPY WITH MINIMAL RESIDUAL DISEASE (MRD) ORIENTED POSTREMISSION STRATEGY IN ADULT PATIENTS WITH LYMPHOBLASTIC LYMPHOMA (PROTOCOL NILG-ALL NO. 09/00) 74
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial 74
Leukemic blasts secondary to myelodysplastic syndromes are molecularly programmed to differentiate into functionally mature dendritic cells 73
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 72
Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity 72
COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome 72
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome 71
One-year mental health outcomes in a cohort of COVID-19 survivors 71
Combined plasma levels of IL-10 and testosterone, but not soluble HLA-G5, predict the risk of death in COVID-19 patients 70
NON-GENOMIC ALTERATIONS IN ANTIGEN PRESENTATION AND T CELL COSTIMULATION ARE DISTINCT DRIVERS OF LEUKEMIA IMMUNE ESCAPE AND RELAPSE AFTER HEMATOPOIETIC CELL TRANSPLANTATION 70
Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey 70
A Phase III Study of Enoxaparin Versus Low-Dose Warfarin Versus Aspirin as Thromboprophylaxis for Patients with Newly Diagnosed Multiple Myeloma Treated up-Front with Thalidomide-Containing Regimens 70
After Action Reviews of COVID-19 response: Case study of a large tertiary care hospital in Italy 70
Autologous haematopoietic stem cell transplantation with thiotepa-cyclophosphamide conditioning in aggressive multiple sclerosis: clinical experience in eight patients 70
Pioglitazone as a novel therapeutic approach in chronic granulomatous disease 70
Totale 9.637
Categoria #
all - tutte 365.721
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 365.721


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021122 0 0 0 0 0 51 20 8 25 1 13 4
2021/2022751 11 2 8 240 55 36 65 102 57 90 27 58
2022/20234.925 1.762 862 248 92 190 567 209 334 392 76 113 80
2023/20243.456 201 226 396 356 327 626 192 273 29 137 179 514
2024/202515.321 1.666 466 330 469 478 1.261 2.153 1.449 2.453 2.072 1.175 1.349
2025/202620.239 3.269 3.468 3.223 6.709 3.355 215 0 0 0 0 0 0
Totale 45.221